Calcified Tissue International

, Volume 92, Issue 5, pp 429–436

Incidence of Hip Fracture in Romania and the Development of a Romanian FRAX Model

  • Daniel Grigorie
  • Alina Sucaliuc
  • Helena Johansson
  • John A. Kanis
  • Eugene McCloskey
Original Research

Abstract

A FRAX® model for Romania calibrated to the total Romanian population was released June 1, 2011. This article describes the data used to develop the Romanian FRAX model and illustrates its features compared to models for other countries. Age- and sex-stratified hip fracture incidence rates and mortality rates for 2010 were extracted from nationwide databases from the age of 40 years. For other major fractures, Romanian incidence rates were imputed, using Swedish ratios for hip to other major osteoporotic fracture (humerus, forearm, and clinically symptomatic vertebral fractures). Fracture incidence rates increased with increasing age: for hip fracture, incidence rates were higher among younger men than women but with a female preponderance from the age of 65 years. The 10-year probability of hip or major fracture was increased in patients with a clinical risk factor (CRF), lower BMI, female gender, higher age, and decreased BMD T score. Of the CRFs, a parental hip fracture accounted for the greatest increase in 10-year fracture probability. The Romanian FRAX tool is the first country-specific fracture prediction model. It is based on the original FRAX methodology, which has been externally validated in several independent cohorts. Despite some limitations, the strengths make the Romanian FRAX tool a good candidate for implementation into clinical practice.

Keywords

FRAX 10-year fracture probability Hip fracture Osteoporotic fracture Osteoporosis 

References

  1. 1.
    Poole KE, Compston JE (2006) Osteoporosis and its management. BMJ 333:1251–1256PubMedCrossRefGoogle Scholar
  2. 2.
    Kanis JA, Oden A, Johnell O, Jonsson B, de Laet C, Dawson A (2001) The burden of osteoporotic fractures: a method for setting intervention thresholds. Osteoporos Int 12:417–427PubMedCrossRefGoogle Scholar
  3. 3.
    Seeley DG, Browner WS, Nevitt MC, Genant HK, Scott JC, Cummings SR (1991) Which fractures are associated with low appendicular bone mass in elderly women? The study of osteoporotic fractures research group. Ann Intern Med 115:837–842PubMedCrossRefGoogle Scholar
  4. 4.
    Kanis JA; World Health Organization Scientific Group (2008) Assessment of osteoporosis at the primary health-care level. Technical report. WHO Collaborating Centre, University of Sheffield, UK. http://www.shef.ac.uk/FRAX/pdfs/WHO_Technical_Report.pdf. Accessed 26 Sept 2012
  5. 5.
    Kanis JA, Johnell O, Oden A, Johansson H, McCloskey EV (2008) FRAX™ and the assessment of fracture probability in men and women from the UK. Osteoporos Int 19:385–397PubMedCrossRefGoogle Scholar
  6. 6.
    Kanis JA, Oden A, Johnell O, Johansson H, De Laet C, Brown J, Burckhardt P, Cooper C, Christiansen C, Cummings S, Eisman JA, Fujiwara S, Gluer C, Goltzman D, Hans D, Krieg MA, La Croix A, McCloskey E, Mellstrom D, Melton LJ 3rd, Pols H, Reeve J, Sanders K, Schott AM, Silman A, Torgerson D, van Staa T, Watts NB, Yoshimura N (2007) The use of clinical risk factors enhances the performance of BMD in the prediction of hip and osteoporotic fractures in men and women. Osteoporos Int 18:1033–1046PubMedCrossRefGoogle Scholar
  7. 7.
    Kanis JA, Odén A, McCloskey EV, Johansson H, Wahl D, Cyrus Cooper C, IOF Working Group on Epidemiology and Quality of Life (2012) A systematic review of hip fracture incidence and probability of fracture worldwide. Osteoporos Int 23:2239–2256PubMedCrossRefGoogle Scholar
  8. 8.
    Kanis JA, Johnell O, De Laet C, Jonsson B, Oden A, Ogelsby AK (2002) International variations in hip fracture probabilities: implications for risk assessment. J Bone Miner Res 17:1237–1244PubMedCrossRefGoogle Scholar
  9. 9.
    Elffors I, Allander E, Kanis JA, Gullberg B, Johnell O, Dequeker J, Dilzen G, Gennari C, Lopez-Vaz AA, Lyritis G, Mazzuoli GF, Miravet L, Passeri M, Perez Cano R, Rapado A, Ribot C (1994) The variable incidence of hip fracture in southern Europe: the MEDOS study. Osteoporos Int 4:253–263PubMedCrossRefGoogle Scholar
  10. 10.
    Grigorie D, Sucaliuc A, Vladescu C (2011) Hip fracture epidemiology in Romania: nationwide study 2005–2009. Osteoporos Int 22(Suppl 1):S323Google Scholar
  11. 11.
    European Commission (2012) Eurostat. http://epp.eurostat.ec.europa.eu. Accessed 25 Sept 2012
  12. 12.
    Kanis JA, Hans D, Cooper C, Baim S, Bilezikian JP, Binkley N, Compston J, Dawson-Hughes B, El-Hajj Fuleihan G, Johansson H, Leslie WD, Lewiecki EM, Luckey MM, Oden A, Papapoulos SE, Poiana C, Wahl DA, McCloskey E, Task Force of the FRAX Initiative l (2011) Interpretation and use of FRAX in clinical practice. Osteoporos Int 22:395–411Google Scholar
  13. 13.
    Tuzun S, Eskiyurt N, Akarırmak U, Sarıdoğan M, Senocak M, Johansson H, Kanis JA, Turkish Osteoporosis Society (2012) Incidence of hip fracture and prevalence of osteoporosis in Turkey: the FRACTURK study. Osteoporos Int 23:949–955PubMedCrossRefGoogle Scholar
  14. 14.
    Clark P, Lavielle P, Franco-Marina F, Ramírez E, Salmerón J, Kanis JA, Cummings SR (2005) Incidence rates and life-time risk of hip fractures in Mexicans over 50 years of age: a population-based study. Osteoporos Int 16:2025–2030PubMedCrossRefGoogle Scholar
  15. 15.
    Czerwinski E, Kanis JA, Trybulec B, Johansson H, Borowy P, Osieleniec J (2009) The incidence and risk of hip fracture in Poland. Osteoporos Int 20:1363–1367PubMedCrossRefGoogle Scholar
  16. 16.
    United Nations, Department of Economic and Social Affairs, Population Division, Population Estimates and Projections Section (2010) World population prospects. http://esa.un.org/unpd/wpp/Documentation/publications.htm. Accessed Nov 2011
  17. 17.
    Cooper C, Cole ZA, Holroyd CR, Earl SC, Harvey NC, Dennison EM, IOF CSA Working Group on Fracture Epidemiology (2011) Secular trends in the incidence of hip and other osteoporotic fractures. Osteoporos Int 22:1277–1288PubMedCrossRefGoogle Scholar
  18. 18.
    Johnell O, Borgstrom F, Jonsson B, Kanis J (2007) Latitude, socioeconomic prosperity, mobile phones and hip fracture risk. Osteoporos Int 18:333–337PubMedCrossRefGoogle Scholar
  19. 19.
    Kanis JA, Passmore R (1989) Calcium supplementation of the diet—I. BMJ 296(137–140):205–208CrossRefGoogle Scholar
  20. 20.
    Grigorie D, Sucaliuc A, Ivan M, Neacsu E, Popa O, Diaconescu A (2008) High prevalence of vitamin D deficiency in 1084 Romanian women with postmenopausal osteoporosis. Acta Endocrinol (Buc) 4:33–45CrossRefGoogle Scholar
  21. 21.
    Johansson H, Kanis JA, McCloskey EV, Odén A, Devogelaer J-P, Kaufman J-M, Neuprez A, Hiliigsmann M, Bruyere O, Reginster JYl (2010) A FRAX® model for the assessment of fracture probability in Belgium. Osteoporos Int 22:453–461PubMedCrossRefGoogle Scholar
  22. 22.
    Papaioannou A, Morin S, Cheung AM, Atkinson S, Brown JP, Feldman S, Hanley DA, Hodsman A, Jamal SA, Kaiser SM, Kvern B, Siminoski K, Leslie WD, Scientific Advisory Council of Osteoporosis Canada (2010) 2010 clinical practice guidelines for the diagnosis and management of osteoporosis in Canada: summary. CMAJ 182:1864–1873PubMedGoogle Scholar
  23. 23.
    Kanis JA McCloskey EV, Johansson H, Cooper C, Rizzoli R, Reginster J-Y; Scientific Advisory Board of the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO) and the Committee of Scientific Advisors of the International Osteoporosis Foundation (IOF) (2013) European guidance for the diagnosis and management of osteoporosis in postmenopausal women. Osteoporos Int 24:23–57Google Scholar
  24. 24.
    Lekawasam S, Adachi JD, Agnusdei D, Bilezikian J, Boonen S, Borgström F, Cooper C, Diez Perez A, Eastell R, Hofbauer L, Kanis JA, Langdahl BL, Lesnyak O, Lorenc R, McCloskey E, Messina OD, Napoli N, Obermayer-Pietsch B, Ralston SH, Sambrook PN, Silverman S, Sosa M, Stepan J, Suppan G, Wahl DA, Compston JE, GIO JointIOF-ECTS, Guidelines Working Group (2012) A framework for the development of guidelines for the management of glucocorticoid-induced osteoporosis. Osteoporos Int 23:2257–2276CrossRefGoogle Scholar
  25. 25.
    Committee of Japanese Guidelines for the Prevention and Treatment of Osteoporosis (2012) The Japanese guidelines for the prevention and treatment of osteoporosis (2011 edition). Life Science Publishing, Tokyo (in Japanese)Google Scholar
  26. 26.
    Compston J, Cooper A, Cooper C, Francis R, Kanis JA, Marsh D, McCloskey EV, Reid DM, Selby P, Wilkins M, National Osteoporosis Guideline Group (NOGG) (2009) Guidelines for the diagnosis and management of osteoporosis in postmenopausal women and men from the age of 50 years in the UK. Maturitas 62:105–108PubMedCrossRefGoogle Scholar
  27. 27.
    Grossman JM, Gordon R, Ranganath VK, Deal C, Caplan L, Chen W, Curtis JR, Furst DE, McMahon M, Patkar NM, Volkmann E, Saag KG (2010) American College of Rheumatology 2010 recommendations for the prevention and treatment of glucocorticoid-induced osteoporosis. Arthritis Care Res (Hoboken) 62:15–26CrossRefGoogle Scholar
  28. 28.
    Dawson-Hughes B, National Osteoporosis Foundation Guide Committee (2008) A revised clinician’s guide to the prevention and treatment of osteoporosis. J Clin Endocrinol Metab 93:2463–2465PubMedCrossRefGoogle Scholar
  29. 29.
    Kanis JA, Johnell O, Oden A, Dawson A, De Laet C, Jonsson B (2001) Ten year probabilities of osteoporotic fractures according to BMD and diagnostic thresholds. Osteoporos Int 12:989–995PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2013

Authors and Affiliations

  • Daniel Grigorie
    • 1
  • Alina Sucaliuc
    • 1
  • Helena Johansson
    • 2
  • John A. Kanis
    • 2
  • Eugene McCloskey
    • 2
  1. 1.Carol Davila University of Medicine, National Institute of EndocrinologyBucharestRomania
  2. 2.WHO Collaborating Centre for Metabolic Bone DiseasesUniversity of Sheffield Medical SchoolSheffieldUK

Personalised recommendations